Related Experiment Video
Updated: Mar 26, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
BCG vaccination is associated with decreased severity of tuberculosis in Pakistan
Zahra Hasan1, Muhammad Irfan1, Javaid A Khan1
1The Aga Khan University, Karachi, Pakistan.
Insights
Bacille Calmette-Guérin (BCG) vaccination may protect against severe tuberculosis (TB) forms in Pakistan. Higher BCG vaccination rates were observed in tuberculous lymphadenitis cases, suggesting localized protection in this high-burden region.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- Pakistan is a high-burden tuberculosis (TB) country, with BCG vaccination administered at birth.
- TB incidence in Pakistan is 231/100,000 population.
- Understanding BCG's effectiveness against different TB forms is crucial for public health strategies.
Purpose of the Study:
- To investigate the association between BCG vaccination status and the severity of tuberculosis in Pakistan.
- To determine if BCG vaccination influences the type of TB infection (pulmonary vs. extrapulmonary) or specific forms like tuberculous lymphadenitis.
Main Methods:
- A cross-sectional, multi-center, hospital-based study.
- Recruited 218 TB patients (pulmonary and extrapulmonary).
- Documented BCG vaccination scar presence and classified TB severity.
Main Results:
- No significant difference in BCG vaccination status was found between pulmonary TB (PTB) and extrapulmonary TB (ETB) cases, or by age and gender.
- A significantly greater number of tuberculous lymphadenitis (LNTB) cases had received BCG vaccinations compared to pleural TB and tuberculous meningitis.
- More vaccinated patients had pulmonary TB than pleural TB.
Conclusions:
- BCG vaccination may offer protection against more severe forms of TB, particularly localized tuberculous lymphadenitis.
- Findings suggest BCG's protective role in specific TB manifestations within a high-burden setting.
- Further research is warranted to elucidate BCG's mechanism of protection against diverse TB presentations.
Abstract:
Vaccination with Bacille Calmette-Guérin (BCG) is given at birth to protect against tuberculosis (TB) in Pakistan. The country ranks 6th amongst high-burden countries worldwide and has an incidence of 231/100,000 pyopulation. This was a cross-sectional multi-center hospital-based study. TB patients (n=218) with pulmonary (PTB, n=120) or extrapulmonary (ETB, 98) were recruited, and the presence of a BCG vaccination scar was documented. Cases were further classified into minimal, moderate and advanced PTB or less severe (L-ETB) or severe disseminated (D-ETB) disease. The association of age, gender and severity of TB infections with BCG vaccination of the individual TB cases was investigated. No difference was found of the BCG vaccination status of PTB and ETB cases, or in relation to age or gender. Patients under 29years of age comprised the largest group. There were more females with ETB than PTB. The largest group within ETB comprised those with tuberculous lymphadenitis (LNTB, 39%). A significantly greater number of LNTB cases had received BCG vaccinations than had those with pleural (unilateral) TB (p=0.004), and tuberculous meningitis (p=0.027) groups. Also, there were more immunized patients with pulmonary as compared with pleural disease (p=0.001). LNTB represents localized granulomatous disease and the observation of higher vaccination rates in this group suggests that BCG has protected against more severe forms of TB in this high-burden region.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Vaccinations

